Applications Published 23 May 2001

Published: 9-Feb-2002

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • Plants, seeds and oils having an elevated total monounsaturated fatty acid content
    Cargill 1100310*

  • Base-triggered release microencapsules
    Syngenta 1100326*

  • Acid-triggered release microcapsules
    Syngenta 1100327*

  • Liquid formulation
    Aventis 1100328*

  • Aqueous growth-reducing compsns
    BASF 1100329*

  • Novel uses of ascorbyl-phosphoryl-cholesterol and compsns for practicing same
    Avon Products 1100432*

  • Anibiotic toothpaste
    Healthshield Technologies 1100445*

  • Topical moisture regulating compsn
    Color Access 1100451*

  • Pharmaceutical conosns and methods for managing skin conditions
    Murad, Howard 1100454*

  • A moldable solid delivery system
    Atrix Laboratories 1100460*

  • Methods of ophthalmic administration
    Insite Vision 1100462*

  • New injectable formulations containing ramoplanin
    Biosearch Italia 1100463*

  • Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier
    Korea Institute of Science and Technology 1100464*

  • Medicinal aerosol formulations
    Jago Research 1100465*

  • Pharmaceutical compsn having improved taste
    Otsuka Pharmaceutical 1100466*

  • Method for making coated gabapentine or pregabaline particles
    Laboratories des Produits Ethiques Ethypharm 1100467*

  • Microparticles with adsorbent aurfaces, methods of making same, and uses thereof Chiron Corp 1100468*

  • Rapidly disintegrable solid preparation
    Takeda Chemical Industries 1100469*

  • Fast dissolving ibuprofen containing compsns having analgesic activity
    Zambon Group 1100470*

  • Compressed compsns comprising clarified xanthan gum
    The Boots Company 1100471*

  • Pharmaceutical compsns comprising ibuprofen and domiperidone
    The Boots Company 1100472*

  • Absorbable brachytherapy and chemotherapy delivery devices and methods
    InnerDyne 1100473*

  • Two-piece capsule for receiving pharmaceutical preparations for powder inhalers
    Boehringer Ingelheim Pharma 1100474*

  • Use of drug-loaded nanoparticles for the treatment of cancers
    Medinova Medical Consulting 1100475*

  • Formulations for the transdermal administration of fenoldopam
    Alza Corp 1100476*

  • Estradiol-containing patch for transdermal administration of hormones
    LTS Lohmann Therapie-Systeme 1100477*

  • Medicinal products with retarded pharmacological activity and method for the production thereof
    Schierholz, Jorg 1100479*

  • Cholinergic agents in the treatment of presbyopia
    Allergan Sales 1100480*

  • Pharmaceutical formulations comprising beclomethasone dipropionate for the treatment of irritable bowel disease
    Chiesi Farmaceutici 1100481*

  • Use of calix(N)arenes for treating fibrotic diseases
    Centre National de la Recherche Scientifique 1100482*

  • Glucocorticoid-selelctive anti-inflammatory agents
    Abbott Laboratories 1100483*

  • Macrophage scavenger receptor antagonists
    SmithKline Beecham 1100484*

  • Substituted anilide compounds and methods
    SmithKline Beecham 1100485*

  • Macrophage scavenger receptor antagonists
    SmithKline Beecham 1100486*

  • Compsns for treating diseases associated with glycosaminoglycan-associated molecular interactions
    Neurochem; Queen's University at Kingston 1100487*

  • Use of creatine compounds for treatment of bone or cartilage cells and tissues
    Synergen 1100488*

  • Method of altering nutritional compounds of milk produced by a lactating animal
    Cornell Research Foundation 1100489*

  • Short contact treatment of acne and photoaging with topical retinoids
    Bershad, Susan 1100490*

  • Ophthalmic compsns for treating occular hypertension
    Merck 1100491*

  • Indole SPLA 2? Inhibitions
    Eli Lilly 1100492*

  • Pharmaceutical compsn comprising an aqueous solution of paclitaxel and albumin
    Novopharm Biotech 1100494*

  • Propenamides as CCR5 modulators
    SmithKline Beecham 1100495*

  • Small molecule inhibitors of BCL-2 proteins
    Thomas Jefferson University 1100496*

  • Heterocyclyl sulphonamide derivatives
    Eli Lilly 1100497*

  • Heterocyclic sulphonamide derivatives
    Eli Lilly 1100498*

  • The use of CD4-binding small molecules to inhibit HIV infection
    Thomas Jefferson University 1100500*

  • Pyrrolidine and pyrroline derivatives having effects on serotonin related systems
    Eli Lilly 1100501*

  • Methods and compsns for treating gastro-esophogeal reflux disease
    Sepracor 1100502*

  • Non-imidazole alkylamines as histamine H 3?-receptor ligands and their therapeutic applications
    Societe Civile Bioprojet 1100503*

  • Pharmaceutical compsns and their uses for treatment of demyelinating disorders
    Eisai 1100504*

  • A pharmaceutical combination comprising a COX-2 inhibitor and an INOS inhibitor
    AstraZeneca 1100505*

  • Integrin receptor antagonists
    Merck 1100506*

  • Antioxidant compsn and method of treating diseases using same
    HME Enterprises 1100507*

  • Pharmaceutical combination comprising a tricyclic compound and at least one of zolopidem, zopiclone, triazolam and brotizolam for treating or preventing sleep disorders
    Takeda Chemical Industries 1100508*

  • Use of biogenic estrogen sulfamates for hormone replacement therapy
    Jenapharm 1100509*

  • Combined preparation of of anti-infectiously active compounds which inhibit the 2-C-methyleryhtrose-4 metabolic pathway and inhibitors of lipid metabolism
    Jomaa, Hassan 1100510*

  • Inhibition of delta-9-desaturase activity by saponins
    Chavali, Sambasiva 1100511*

  • Preparation of thioarabinofuranosyl compounds and use thereof
    Southern Research Institute 1100512*

  • Autoinducer synthase modulating compounds and uses thereof
    University of Iowa Research Foundation 1100513*

  • Injectable anaesthetic containing noble gas
    Messer Griesheim 1100514*

  • Ex vivo treatment of allogenic and xenogeneic T-cells with BP39 antagonists
    Regents of the University of Minnesota 1100515*

  • Extracts of feverfew (Tanacetum parthenium) against inflammatory disorders
    Johnson & Johnson 1100516*
    See more

    • You may also like

    APPLICATIONS PUBLISHED 29 MAY 2002

    Read more
    The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492

    Trending Articles

    1. Optimising RNA production for faster and cheaper pharmaceutical manufacturing RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the avoidance of scaling issues
    2. ChargePoint invest in a single-use manufacturing facility to expand product line The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
    3. Memel Biotech and Therabest collaborate to develop exosome-based cell therapies The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
    4. Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
    5. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020

    Upcoming event

    Cleanroom Conference UK

    22–23 May 2024 | Exhibition | Birmingham, UK     See all

    You may also like

    APPLICATIONS PUBLISHED 29 MAY 2002

    The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
    Manufacturing

    Innovation in generics: increased efficiency through peptide API synthesis expertise

    Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
    Regulatory

    Broughton receives flexible scope ISO 17025 accreditation

    New certification allows accreditation without prior approval
    Research & Development

    N4 Pharma and SRI to target and treat previously unreachable human cells

    The companies will collaborate to perform research to conjugate SRI’s MGS system to Nuvec to increase intracellular delivery to specific target cells.
    Finance

    Berry Global invests to increase production capacity for healthcare products

    Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
    Manufacturing

    For easy transition from glass to plastic accessories - BOLA components with GL threads

    The GL thread is the most common thread on lab equipment made of glass. Available from Labtex in the UK, BOLA offers a modular construction system with many different components with GL threads
    Distribution

    ChargePoint invest in a single-use manufacturing facility to expand product line

    The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
    Subscribe now